New York State Common Retirement Fund Has $1.75 Million Stake in Sotera Health (NASDAQ:SHC)

New York State Common Retirement Fund decreased its position in Sotera Health (NASDAQ:SHC) by 20.6% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 103,777 shares of the company’s stock after selling 26,911 shares during the period. New York State Common Retirement Fund’s holdings in Sotera Health were worth $1,749,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Sotera Health by 61.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,921 shares of the company’s stock valued at $403,000 after purchasing an additional 9,090 shares during the period. Louisiana State Employees Retirement System bought a new position in shares of Sotera Health during the 4th quarter worth approximately $468,000. Allspring Global Investments Holdings LLC increased its stake in shares of Sotera Health by 21.5% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 602,802 shares of the company’s stock valued at $10,157,000 after acquiring an additional 106,742 shares in the last quarter. Pacer Advisors Inc. lifted its position in shares of Sotera Health by 79.4% during the 4th quarter. Pacer Advisors Inc. now owns 14,864 shares of the company’s stock valued at $250,000 after acquiring an additional 6,580 shares during the period. Finally, Teachers Retirement System of The State of Kentucky boosted its stake in Sotera Health by 92.8% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 33,890 shares of the company’s stock worth $507,000 after acquiring an additional 16,311 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $11.22 on Thursday. The company has a market cap of $3.17 billion, a PE ratio of 59.03 and a beta of 2.08. The company has a quick ratio of 2.86, a current ratio of 3.20 and a debt-to-equity ratio of 5.39. Sotera Health has a 52 week low of $10.71 and a 52 week high of $19.40. The business has a 50 day moving average price of $12.22 and a 200-day moving average price of $13.98.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.26 earnings per share for the quarter, meeting the consensus estimate of $0.26. Sotera Health had a return on equity of 48.47% and a net margin of 5.09%. The business had revenue of $310.24 million for the quarter, compared to analysts’ expectations of $302.17 million. During the same period last year, the business earned $0.23 EPS. The business’s revenue was up 23.3% on a year-over-year basis. Equities analysts anticipate that Sotera Health will post 0.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently weighed in on SHC. Citigroup upgraded shares of Sotera Health from a “neutral” rating to a “buy” rating and dropped their price objective for the company from $18.00 to $16.00 in a report on Wednesday, April 3rd. Barclays cut their price target on Sotera Health from $19.00 to $14.00 and set an “overweight” rating on the stock in a report on Wednesday, April 10th. Jefferies Financial Group raised Sotera Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $15.00 to $15.50 in a research note on Monday, March 25th. TheStreet raised Sotera Health from a “d” rating to a “c-” rating in a research report on Tuesday, February 27th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $20.00 price target on shares of Sotera Health in a research report on Monday, March 4th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $17.70.

Insider Buying and Selling

In other news, Director Pincus & Co. Warburg sold 16,594,363 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.31, for a total value of $237,465,334.53. Following the completion of the transaction, the director now directly owns 88,822,952 shares of the company’s stock, valued at $1,271,056,443.12. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Sotera Health news, insider Michael P. Rutz sold 83,109 shares of Sotera Health stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.31, for a total value of $1,189,289.79. Following the sale, the insider now owns 544,409 shares of the company’s stock, valued at $7,790,492.79. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Pincus & Co. Warburg sold 16,594,363 shares of the business’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.31, for a total transaction of $237,465,334.53. Following the completion of the transaction, the director now owns 88,822,952 shares in the company, valued at $1,271,056,443.12. The disclosure for this sale can be found here. 55.12% of the stock is owned by corporate insiders.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.